Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival
NCT06900686 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 458
Last updated 2025-03-28
Summary
This trial is a single-center retrospective study. Eligible patients receiving PD-1 inhibitor treatment will enrolled.
Conditions
Interventions
- DRUG
-
PD1 Inhibitor
PD1 Inhibitor
Sponsors & Collaborators
-
Yanhong Deng
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-20
- Primary Completion
- 2022-09-20
- Completion
- 2025-03-23
More Related Trials
-
Celecoxib in Treating Patients With Early-Stage Rectal Cancer
NCT00608595 ·Status: TERMINATED ·Phase: NA
-
Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer
NCT00077259 ·Status: COMPLETED ·Phase: PHASE2
-
Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
NCT00004195 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of ES104 in Patients With Metastatic Colorectal Cancer
NCT05167448 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Feasibility of PD-1 Blockade in the Treatment of dMMR or MSI-H Rectal Cancer
NCT04357587 ·Status: COMPLETED ·Phase: PHASE1
-
EPO906 Therapy in Patients With Advanced Colorectal Cancer
NCT00035087 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy
NCT00940758 ·Status: COMPLETED ·Phase: PHASE1
-
Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT00003544 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
NCT06663319 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer
NCT00975897 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
NCT00002933 ·Status: COMPLETED ·Phase: PHASE2
-
Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer
NCT03592641 ·Status: TERMINATED ·Phase: PHASE2
-
Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer
NCT02068131 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer
NCT00506571 ·Status: UNKNOWN ·Phase: PHASE2
-
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
NCT04729322 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Stage II/III Colorectal Cancer Recurrence
NCT06314958 ·Status: RECRUITING
-
A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.
NCT07263178 ·Status: RECRUITING
-
Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer
NCT01386242 ·Status: COMPLETED ·Phase: PHASE2
-
S9923 R115777 in Treating Patients With Advanced Colorectal Cancer
NCT00005833 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
NCT00838578 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer
NCT03290937 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer
NCT06692959 ·Status: RECRUITING ·Phase: PHASE2
-
Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer
NCT00003220 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III
NCT01196260 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer
NCT03567629 ·Status: UNKNOWN ·Phase: PHASE2